STIGMATIZATION IN ALZHEIMER'S DISEASE RESEARCH ON AFRICAN AMERICAN ELDERS

REFERENCES

• Alda M., Hrdina P. D. Distribution of platelet 5-HT2A receptor densities in suicidal and non-suicidal depressives and control subjects. Psychiatry Research 2000; 94: 273–277, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Alzheimer's Association (2004a) Researcher: General statistics/demographics. September, 42004, http://www.alz.org/AboutAD/statistics.asp
   Google Scholar
• Alzheimer's Association. African-Americans and Alzheimer's disease: The silent epidemic. Alzheimer's Association, Chicago 2004b
   Google Scholar
• American Health Assistance Foundation (2004) Amyloid plaques and neurofibrillary tangles. January, 32005, http://www.ahaf.org/alzdis/about/AmyloidPlaques.htm
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th ed. Author, Washington, DC 2000
   Google Scholar
• Assal F., Cummings J. L. Neuropsychiatric symptoms in the dementias. Current Opinion in Neurology. 2002; 15: 445–450, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Auer S. R., Monteiro I. M., Reisberg B. The empirical behavioral pathology in Alzheimer's disease (E-BEHAVE-AD) rating scale. International Psychogeriatrics. 1996; 8: 247–265, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Auer S. R., Sclan S. G., Yaffee R. A., Reisberg B. The neglected half of Alzheimer disease: Cognitive and functional concomitants of severe dementia. Journal of the American Geriatrics Society 1994; 42: 1266–1272, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Barbanti P., Fabbrini G., Ricci A., Bruno G., Cerbo R., Bronzetti E., Amenta F., Luigi Lenzi G. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mechanisms of Ageing and Development 2000; 120(1)65–75, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Barbanti P., Fabbrini G., Ricci A., Pascali M. P., Bronzetti E., Amenta F. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 2000; 20(1)15–19, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bazargan M., Bazargan S., King L. Paranoid ideation among elderly African American persons. The Gerontologist. 2001; 41: 366–372, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bennett D. A., Wilson R. S., Schneider J. A., Evans D. A., Aggarwal N. T., Arnold S. E., Cochran E. J., Berry-Kravis E., Bienias J. L. Apolipoprotein E ε 4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003; 60: 246–252, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Benoit M., Robert P. Depression and apathy in Alzheimer's disease [in French]. Presse Medicale 2003; 32: S14–S18, 24 Suppl[CSA]
   Google Scholar
• Bergman H., Chertkow H., Wolfson C., Stern J., Rush C., Whitehead V., Dixon R. HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. Journal of American Geriatrics Society 1997; 45: 15–20, [CSA]
   PubMed Web of Science ®Google Scholar
• Bird T. D. (2003) Alzheimer's disease overview. June, 22004, http://www.genetests.org
   Google Scholar
• Bishopric N. H., Cohen H. J., Lefkowitz R. J. Beta adrenergic receptors in lymphocyte subpopulations. Journal of Allergy and Clinical Immunology 1980; 65(1)29–33, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Bobinski M., de Leon M. J., Tarnawski M., Wegiel J., Bobinski M., Reisberg B., Miller D. C., Wisniewski H. M. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Research. 1998; 805: 267–269, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bonelli R. M., Aschoff A., Niederwieser G., Heuberger C., Jirikowski G. Cerebrospinal fluid tissue transglutaminase as α biochemical marker for Alzheimer's disease. Neurobiology of Disease. 2002; 11: 106–110, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Breitner J. C., Wyse B. W., Anthony J. C., Welsh-Bohmer K. A., Steffens D. C., Norton M. C., Tschanz J. T., Plassman B. L., Meyer M. R., Skoog I., Khachaturian A. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: The Cache County Study. Neurology. 1999; 53: 321–331, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bretsky P., Guralnik J. M., Launer L., Albert M., Seeman T. E. The role of APOE-E4 in longitudinal cognitive decline: MacArthur studies of successful aging. Neurology. 2003; 60: 1077–1081, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cardebat D., Démonet J. -F., Puel M., Agniel A., Viallard G., Celsis P. Brain correlates of memory processes in patients with dementia of Alzheimer's type: A SPECT activation study. Journal of Cerebral Blood Flow Metabolism. 1998; 18: 457–462, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Chee I. S., Lee S. W., Kim J. L., Wang S. K., Shin Y. O., Shin S. C. 5-HT2A receptor gene promoter polymorphism –1438A/G and bipolar disorder. Psychiatric Genetics. 2001; 11: 111–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Coffey C. E., Cummings J. L. Textbook of geriatric neuropsychiatry 2nd ed. American Psychiatric Press, Washington, DC 2000
   Google Scholar
• Cohen C. I., Magai C. Racial differences in neuropsychiatric symptoms among dementia outpatients. Journal of Geriatric Psychiatry. 1999; 7: 57–63, [CSA]
   Google Scholar
• Connell C. M., Shaw B. A., Holmes S. B., Foster N. L. Caregivers' attitudes toward their family members' participation in Alzheimer disease research: Implications for recruitment and retention. Alzheimer Disease and Associated Disorders 2001; 15(3)137–145, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of Apolipoprotein e type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261: 921–923, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cummings J. L. Alzheimer's disease. New England Journal of Medicine 2004; 351(1)56–67, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Davis K. L., Mohs R. C., Marin D., Purohit D. P., Perl D. P., Lantz M. Cholinergic markers in elderly patients with early signs of Alzheimer disease. Journal of American Medical Association. 1999; 281: 1401–1406, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Derouesné C., Thibault S., Kagha-Pierucci S., Baudouin-Madec V., Ancri D., Lacomblez L. Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. International Journal of Geriatric Psychiatry. 1999; 14: 1019–1030, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Desai P. P., Bunker C. H., Ukoli F. A. M., Kamboh M. I. Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis. 2002; 163: 329–338, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Desai P. P., Hendrie H. C., Evans R. M., Murrell J. R., DeKosky S. T., Kamboh M. I. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. American Journal of Medical Genetics—Part B (Neuropsychiatric Genetics) 2003; 116B: 98–110, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Desgranges B., Baron J. -C., de la Sayette V., Petit-Taboué M. -C., Benali K., Landeau B., Lechevalier B., Eustache F. The neural substrates of memory systems impairment in Alzheimer's disease: A PET study of resting brain glucose utilization. Brain. 1998; 121: 611–631, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dilworth-Anderson P., Gibson B. E. The cultural influence of values, norms, meanings, and perceptions in understanding dementia in ethnic minorities. Alzheimer Disease and Associated Disorders 2002; 16: S56–S63, Supple 2[PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Drayna D. T., McLean J. W., Wion K. L., Trent J. M., Drabkin H. A., Lawn R. M. Human apolipoprotein D gene: Gene sequence, chromosome localization, and homology to the a 2u-globulin superfamily. DNA. 1987; 6: 199–204, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Drevets W. C., Rubin E. H. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biological Psychiatry 1989; 25(1)39–48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Du L., Bakish D., Hrdina P. D. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatric Genetics 2000; 10(4)159–164, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Du L., Bakish D., Lapierre Y. D., Ravindran A. V., Hrdina P. D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics). 2000; 96: 56–60, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Duffy F. H., Albert M. S., McAnulty G. B. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Annals of Neurology. 1984; 16: 439–448, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Eaves Y. D. Family recruitment issues and strategies: Caregiving in rural African Americans. Nursing Research. 1999; 48: 183–187, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Espino D. V., Lewis R. Dementia in older minority populations: Issues of prevalence, diagnosis, and treatment. American Journal of Geriatric Psychiatry 1998; 6: S19–S25, [PUBMED], [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Espiritu D. A., Rashid H., Mast B. T., Fitzgerald J., Steinberg J., Lichtenberg P. A. Depression, cognitive impairment and function in Alzheimer's disease. International Journal of Geriatric Psychiatry. 2001; 16: 1098–1103, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Eustace A., Kidd N., Greene E., Fallon C., Ni Bhrain S., Cunningham C., Coen R., Walsh J. B., Coakley D., Lawlor B. A. Verbal aggression in Alzheimer's disease: Clinical functional and neuropsychological correlates. International Journal of Geriatric Psychiatry. 2001; 16: 858–861, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Evans D. A., Bennett D. A., Wilson R. S., Bienias J. L., Morris M. C., Scherr P. A., Herbert L. E., Aggarwal N., Beckett L. A., Joglekar R., Berry-Kravis E., Schneider J. Incident of Alzheimer disease in a biracial urban community: Relation to apolipoprotein E allele status. Archives of Neurology. 2003; 60: 185–189, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Farber N. B., Rubin E. H., Newcomer J. W., Kinscherf D. A., Miller J. P., Morris J. C., Alney J. W., McKeel D. W., Jr. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Archives of General Psychiatry. 2000; 57: 1165–1173, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fernández G., Tendolkar I. Integrated brain activity in medial temporal and prefrontal areas predicts subsequent memory performance: Human declarative memory formation at the system level. Brain Research Bulletin 2001; 55(1)1–9, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fillenbaum G. G., Heyman A., Huber M. S., Ganguli M., Unverzagt F. W. Performance of elderly African American and white community residents on the CERAD neuropsychological battery. Journal of the International Neuropsychological Society. 2001; 7: 502–509, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Förstl H., Besthorn C., Geiger-Kabisch C., Sattel H., Schreiter-Gasser U. Psychotic features and the course of Alzheimer's disease: Relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatrica Scandinavica. 1993; 87: 395–399, [CSA]
   PubMed Web of Science ®Google Scholar
• Franssen E. H., Reisberg B. Neurologic markers of the progression of Alzheimer's disease. International Psychogeriatrics 1997; 9: 297–306, 317–321 Supple 1[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Franssen E. H., Souren L. E., Torossian C. L., Reisberg B. Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease. Journal of the American Geriatrics Society. 1999; 47: 463–469, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Freels S., Nyenhuis D. L., Gorelick P. B. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology. 2002; 59: 1146–1153, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Frisoni G. B., Rozzini L., Gozzetti A., Binetti G., Zanetti O., Bianchetti A., Trabucchi M., Cummings J. L. Behavioral syndromes in Alzheimer's disease: Description and correlates. Dementia and Geriatric Cognitive Disorders 1999; 10(1)130–138, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Froehlich T. E., Bogardus S. T., Inouye S. K. Dementia and race: Are there differences between African Americans and Caucasians. Journal of the American Geriatric Society 2001; 49: 477–484, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gélinas I., Gauthier L., McIntyre M., Gauthier S. Development of a functional measure for persons with Alzheimer's disease: The disability assessment of dementia. The American Journal of Occupational Therapy. 1999; 53: 471–481, [CSA]
   PubMed Web of Science ®Google Scholar
• Goate A., Chartier-Harlin M. -C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R., Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M., Roses A., Williamson R., Rossor M., Owen M., Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349: 704–706, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Golde T. E. Alzheimer disease therapy: Can the amyloid cascade be halted?. The Journal of Clinical Investigation 2003; 111(1)11–18, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Goldstein F. C., Ashley A. V., Gearing M., Hanfelt J., Penix L., Freedman L. J., Levey A. I. Apolipoprotein E and age at onset of Alzheimer disease in African American patients. Neurology 2001; 57(10)1923–1925, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Graff-Radford N. E., Green R. C., Go R. C. P., Hutton M. L., Edeki T., Bachman D. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Archives of Neurology. 2002; 59: 594–600, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Green R. C., Cupples L. A., Go R., Benke K. S., Edeki T., Griffith P. A., Williams M., Hipps Y., Graff-Radford N., Bachman D., Farrer L. A., MIRAGE Study Group. Risk of dementia among white and African American relatives of patients with Alzheimer disease. Journal of American Medical Association. 2002; 287: 329–336, [CSA]
   PubMed Web of Science ®Google Scholar
• Gruber O., Indefrey P., Steinmetz H., Kleinschmidt A. Dissociating neural correlates of cognitive components in mental calculation. Cerebral Cortex. 2001; 11: 350–359, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Grusendorf P. EEGs in cognitive stages of Alzheimer's-type dementia. Journal of Neuroscience in Nursing 1994; 26(1)42–46, [CSA]
   PubMedGoogle Scholar
• Gurland B. J., Wilder D. E., Lantigua R., Stern Y., Chen J., Killeffer E. H. P., Mayeux R. Rates of dementia in three ethnoracial groups. International Journal of Geriatric Psychiatry. 1999; 14: 481–493, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hargrave R., Stoeklin M., Haan M., Reed B. Clinical aspects of Alzheimer's disease in black and white patients. Journal of the National Medical Association. 1998; 90: 78–84, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Harwood D. G., Barker W. W., Ownby R. L., Duara R. Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer's disease. International Journal of Geriatric Psychiatry. 2000; 15: 393–400, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Harwood D. G., Sultzer D. L., Wheatley M. V. Impaired insight in Alzheimer disease: Association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2000; 13(1)83–88, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hendrie H. C., Ogunniyi A., Hall K. S., Baiyewu O., Unverzagt F. W., Gureje O., Gao S., Evans R. M., Ogunseyinde A. O., Adeyinka A. O., Musick B., Hui S. L. Incidence of dementia and Alzheimer disease in two communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. Journal of American Medical Association. 2001; 285: 739–747, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Herbert L. E., Wilson R. S., Gilley D. W., Beckett L. A., Scherr P. A., Bennett D. A., Evans D. A. Decline of language among women and men with Alzheimer's disease. The Journals of Gerontology—Series B: Psychological Sciences and Social Sciences 2000; 55B(6)P354–P361, [CSA]
   Google Scholar
• Heyman A., Peterson B., Fillenbaum G., Pieper C. The consortium to establish a registry of Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 1996; 46: 656–660, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hock C., Heese K., Muller-Spahn F., Huber P., Risesen W., Nitsch R. M., Otten U. Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression. Molecular Psychiatry. 2000; 5: 510–513, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Holmes C., Arranz M. J., Powell J. F., Collier D. A., Lovestone S. 5-HT 2A and 5-HT 2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Human Molecular Genetics. 1998; 7: 1507–1509, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Holston E. C. The relationship between the abnormal electrophysiological features and the degeneration in cognition, behavior, daily functioning, and global presentation manifested by individuals with Alzheimer's disease. Dissertation Abstracts International 2003; 64(08)3743, (UMI#AAT 3100793)[CSA]
   Google Scholar
• Ikawa M., Nakanishi M., Furukawa T., Nakaaki S., Hori S., Yoshida S. Relationship between EEG dimensional complexity and neuropsychological findings in Alzheimer's disease. Psychiatry and Clinical Neurosciences. 2000; 54: 537–541, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ingram V. Alzheimer's disease: The molecular origins of the disease are coming to light, suggesting several novel therapies. American Scientist. 2003; 91: 312–321, [CROSSREF], [CSA]
   Google Scholar
• John E. R., Prichep L. S., Friedman J., Easton P. Neurometrics: Computer-assisted differential diagnosis of brain dysfunctions. Science 1988b; 293: 162–169, [CSA]
   Web of Science ®Google Scholar
• Joseph R. Neuropsychiatry, neuropsychology, and clinical neuroscience: Emotion, evolution, cognition, language, memory, brain damage, and abnormal behavior 2nd ed. Williams & Wilkins, Baltimore, MD 1996
   Google Scholar
• Knott V., Mohr E., Mahoney C., Ilivitsky V. Quantitative electroencephalography in Alzheimer's disease: Comparison with a control group, population norms and mental status. Journal of Psychiatry Neurosciences 2001; 26(2)106–116, [CSA]
   PubMed Web of Science ®Google Scholar
• Kwak Y. T., Koo M. -S., Choi C. -H., Sunwoo I. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Medical Genetics 2001; 2(3), [On-line]. Available: http://www.biomedcentral.com/1471-2350/2/3.[10/02/2004], [CSA]
   PubMedGoogle Scholar
• Lai M. K., Lai O. F., Keene J., Esiri M. M., Francis P. T., Hope T., Chen C. P. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex. Neurology. 2001; 57: 805–811, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lawton M. P. Aging and performance of home task. Human Factors. 1990; 32: 527–536, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lazeyras F., Charles H. C., Tupler L. A., Erickson R., Boyko O. B., Ranga Rama Krishnan K. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Research: Neuroimaging. 1998; 82: 95–106, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lee K. U., Lee J. S., Kim K. W., Jhoo J. H., Lee D. Y., Yoon J. C., Lee J. H., Lee D. S., Lee M. C., Woo J. I. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients. The Journal of Neuropsychiatry and Clinical Neurosciences. 2003; 15: 78–83, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Leon J., Lair T. Functional status of the noninstitutionalized elderly: Estimates of ADL and IADL difficulties. Agency for Health Care Policy and Research, Rockville 1990
   Google Scholar
• Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K., Crowley A. C., Fu Y. -H., Guenette S. Y., Galas D., Nemens E., Wijsman E. M., Bird T. D., Schellenberg G. D., Tanzi R. E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995; 269: 973–977, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lindau M., Jelic V., Johansson S. -E., Andersen C., Wahlund L. -O., Almkvist O. Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 2003; 15: 106–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Maddock R. J., Garrett A. S., Buonocore M. H. Remembering familiar people: The posterior cingulated cortex and autobiographical memory retrieval. Neuroscience. 2001; 104: 667–676, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Massat I., Souery D., Lipp O., Blairy S., Papadimitriou G., Dikeos D., Ackenheil M., Fuchshuber S., Hilger C., Kaneva R., Milanova V., Verheyen G., Raeymaekers P., Staner L., Oruc L., Jakovljevic M., Serretti A., Macciardi F., Van Broeckhoven C. A European multicenter association study of HTR2A receptor polymorphism in bipolar affective disorder. American Journal of Medical Genetics. 2000; 96: 136–140, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miller B. L., Gustavson A. Alzheimer's disease and frontotemporal dementia. Textbook of geriatric neuropsychiatry 2nd ed., C. E. Coffey, J. L. Cummings. American Psychiatric Press, Washington, DC 2000; 511–529
   Google Scholar
• Minov C., Baghai T. C., Shüle C., Zwanzger P., Schwarz M. J., Zill P., Rupprecht R., Bondy B. Serotonin-2A-receptor and—transporter polymorphisms: lack of association in patients with major depression. Neuroscience Letters. 2001; 303: 119–122, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Monteiro I., Boksay I., Auer S., Torossian C., Sinaiko E., Reisberg B. Reliability of routine clinical instruments for the assessment of Alzheimer's disease administered by telephone. Journal of Geriatric Psychiatry & Neurology 1998; 11(1)18–24, [CSA]
   PubMed Web of Science ®Google Scholar
• Moreno F. A., Gelenberg A. J., Heninger G. R., Porter R. L., McKnight K. M., Allen J., Phillips A. P., Delgado P. L. Tryptophan depletion and depressive vulnerability. Biological Psychiatry. 1999; 46: 498–505, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Mullan M., Houlden H., Windelspecht M., Fidani L., Lombardi C., Diaz P., Rossor M., Crook R., Hardy J., Duff K., Crawford F. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nature Genetics 1992; 2(4)340–342, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Myers A. J., Goate A. M. The genetics of late-onset Alzheimer disease. Current Opinions in Neurology. 2001; 14: 433–440, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Nacmias B., Tedde A., Forleo P., Piacentini S., Guarnieri B. M., Bartoli A., Ortenzi L., Petruzzi C., Serio A., Marcon G., Sorbi S. Association between 5-HT 2A receptor polymorphism and psychotic symptoms in Alzheimer's disease. Biological Psychiatry. 2001; 50: 472–475, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• National Chronic Care Consortium and the Alzheimer's Association. Tools for the assessment and treatment of dementia in managed care settings: A publication of the chronic care networks for Alzheimer's disease initiative. National Chronic Care Consortium, Bloomington, MN 2001
   Google Scholar
• Navarro A., del Valle E., Astudillo A., González del Rey C., Tolivia J. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral B amyloid deposits. Experimental Neurology. 2003; 184: 697–704, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ni X., Trakalo J. M., Mundo E., Lee L., Parikh S., Kennedy J. L. Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder. NeuroMolecular Medicine. 2002; 2: 251–259, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ogilvie A. D., Battersby S., Bubb V. J., Fink G., Harmar A. J., Goodwin G. M., Smith C. A. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996; 347: 1–7, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Oliveira J. R., Gallindo R. M., Maia L. G. S., Brito-Marques P. R., Otto P. A., Passos-Bueno M. R., Morais M. A., Jr., Zatz M. The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease. Molecular Psychiatry. 1998; 3: 438–441, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Palotàs A., Puskas L. G., Kitajka K., Palotàs M., Molnar J., Pakaski M., Janka Z., Penke B., Kalman J. The effect of citalopram on gene expression profile of Alzheimer lymphocytes. Neurochemical Research. 2004; 8: 1563–1570, [CSA]
   Google Scholar
• Patterson M. B., Schnell A. H., Martin R. J., Mendez M. F., Smyth K. A., Whitehouse P. J. Assessment of behavioral and affective symptoms in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 1990; 3(1)21–30, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Pericak-Vance M. A., Bebout J. L., Gaskell P. C., Yamaoka L. H., Hung W. -Y., Alberts M. J., Walker A. P., Bartlett R. J., Haynes C. A., Welsh K. A. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. American Journal of Human Genetics. 1991; 48: 1034–1050, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Perry R. J., Hodges J. R. Relationship between functional and neuropsychological performance in early Alzheimer disease. Alzheimer Disease and Associated Disorders 2000; 14(1)1–10, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Perry R. T., Collins J. S., Harrell L. E., Acton R. T., Go R. C. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. American Journal of Medical Genetics 2001; 105(4)332–342, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ponomareva N. V., Selesneva N. D., Jarikov G. A. EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology. 2003; 48: 152–159, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Prichep L. S., John E. R., Ferris S. H., Reisberg B., Almas M., Alper K., Cancro R. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiology of Aging 1994; 15(1)85–90, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Quzilbash N., Whitehead A., Higgins J., Wilcock G., Schneider L., Farlow M. Cholinesterase inhibition for Alzheimer disease. Journal of American Medical Association. 1996; 280: 1777–1782, [CROSSREF], [CSA]
   Google Scholar
• Reisberg B. Senile dementia. The encyclopedia of aging: A comprehensive resource in gerontology and geriatrics 2nd ed., G. L. Maddox, R. C. Atchley, J. G. Evans, C. E. Finch, D. F. Hutlsch, R. A. Kane, M. D. Mezey, I. C. Siegler. Springer, New York 1995; 838–847
   Google Scholar
• Reisberg B., Finkel S., Overall J., Schmidt-Gollas N., Kanowski S., Lehfeld H., Hulla F., Sclan S. G., Wilms H. U., Heininger K., Hindmarch I., Stemmler M., Poon L., Kluger A., Cooler C., Bergener M., Hugonot-Diener L., Robert P. H., Antipolis S., Erzigkeit H. The Alzheimer's disease activities of daily living international scale (ADL-IS). International Psychogeriatrics 2001; 13(1)163–181, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Reisberg B., Kenowsky S., Franssen E. H., St. Auer R., Souren L. E. M. Towards a science of Alzheimer's disease management: A model based upon current knowledge of retrogenesis. International Psychogeriatrics 1999; 11(1)7–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ricci A., Bronzetti E., Mignini F., Tayebati S. K., Zaccheo D., Amenta F. Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. Journal of Neurology. 1999; 96: 234–240, [CSA]
   Google Scholar
• Ripich D. N., Carpenter B., Ziol E. Comparison of African-American and white persons with Alzheimer's disease on language measures. Neurology. 1997; 48: 781–783, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ripich D. N., Fritsch T., Ziol E. Everyday problem solving in African Americans and European Americans with Alzheimer's disease: An exploratory study. International Psychogeriatrics 2002; 14(1)83–85, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rippon G. A., Crook R., Baker M., Halvorsen E., Chin S., Hutton M., Houlden H., Hardy J., Lynch T. Presenilin 1 mutation in an African American family presenting with atypical Alzheimer dementia. Archives of Neurology. 2003; 60: 884–888, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rocc P., De Leo C., Eva C., Marchiaro L., Milani A. M., Musso R., Ravizza L., Zanalda E., Bogetto F. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Progress in Neuro-psychopharmacology & Biological Psychiatry. 2002; 26: 1155–1160, [CSA]
   PubMedGoogle Scholar
• Rodriguez G., Copello F., Vitali P., Perego G., Nobili F. Clinical Insight: EEG spectral profile to stage Alzheimer's disease. Clinical Neurophysiology. 1999; 110: 1831–1837, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Llang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P. E., Rommens J. M., St. George-Hyslop P. H. Familial Alzheimer's diseases in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995; 376: 775–778, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sahota A., Yang M., Gao S. J., Hui S. L., Baiyewu O., Guriji O., Oluwole S., Ogunniyi A., Hall K. S., Hendrie H. C. Apolipoprotein E-associated risk For Alzheimer's disease in the African-American population is genotype dependent. Annals of Neurology 1997; 42(4)659–661, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Samuel W., Caligiuri M., Galasko D., Lacro J., Marini M., McClure F. S., Warren K., Jeste D. V. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study. International Journal of Geriatric Psychiatry. 2000; 15: 794–802, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schellenberg G. D., Bird T. D., Wijsman E. M., Orr T. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E., Potter H., Heston L. L., Martin G. M. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992; 258: 668–671, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schneider L. S., Dagerman K. S. Psychosis of Alzheimer's disease: Clinical characteristics and history. Journal of Psychiatric Research 2004; 38: 105–111, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Schröter A., Mergl R., Bürger K., Hampel H., Möller H. -J., Hegerl U. Kinematic analysis of handwriting movements in patients with Alzheimer's disease, mild cognitive impairment, depression and healthy subjects. Dementia and Geriatric Cognitive Disorders 2003; 15(1)132–142, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Shadlen M. -F., Larson E. B., Gibbon S. L., McCormick W. C., Teri L. Alzheimer's disease symptom severity in blacks and whites. Journal of American Geriatric Society. 1999; 47: 482–486, [CSA]
   PubMed Web of Science ®Google Scholar
• Shadlen M -F., Larson E. B., Yukawa M. The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: The search for etiological clues. Neurobiology of Aging. 2000; 21: 171–181, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shenkman L., Rabey J. M., Gilad G. M. Cholinergic muscarinic binding by rat lymphocytes: Effects of antagonist treatment, strain and aging. Brain Research. 1986; 380: 303–308, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Singh A. N., Barlas C., Saeedi H., Mishra R. K. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia. Journal of Psychiatry Neuroscience 2003; 28(1)39–47, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Smith-Gamble V., Baiyewu O., Perkins A. J., Gureje O., Hall K. S., Ogunniyi A., Hui S. L., Hendrie H. C. Informant reports of changes in personality predict dementia in a population-based study of elderly African Americans and Yoruba. American Journal of Geriatric Psychiatry 2002; 10: 724–732, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• St. George-Hyslop P., Hainer J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J. -F., Montesi M., Bruni A., Sorbi S., Rainero I., Pinessi L., Pollen D., Polinsky R., Nee L., Kennedy J., Macciardi F., Rogaeva E., Liang Y., Alexandrova N., Lukiw W., Schlumpf K., Tanzi R., Tsuda T., Farrer L., CAntu J. -M., Duara R., Amaducci L., Bergamini L., Gusella J., Roses A., Crapper McLachlan D. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics. 1992; 2: 330–333, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• St. George-Hyslop P., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D., Growdon J., Bruni A., Foncin J. F., Salmon D., Frommelt P., Amaducci L., Sorbi S., Piacentini S., Stewart G. D., Hobbs W. J., Conneally P. M., Gusella J. F. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 1987; 235: 885–890, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stanford E. P., Dubois B. Alzheimer's disease and related disorders among African-Americans. Neuroepidemiology, theory, and method, C. Molgaard. Academic, New York 1993; 195–210
   Google Scholar
• Stanisz A. N., Scicchitano R., Dazin P., Bienenstock J., Payan D. G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. Journal of Immunology. 1987; 35: 749–756, [CSA]
   Google Scholar
• Stephenson J. Racial barriers may hamper diagnosis, care of patients with Alzheimer disease. Journal of American Medical Association. 2001; 286: 779–780, [CROSSREF], [CSA]
   Google Scholar
• Stern Y., Albert S., Tang M. -X., Tsai W -Y. Rate of memory decline in AD is related to education and occupation. Neurology. 1999; 53: 1942–1947, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sweet R. A., Nimgaonkar V. L., Kamboh M. I., Lopez O. L., Zhang F., DeKosky S. T. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Archives of Neurology. 1998; 55: 1335–1340, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Takahashi N., Nagai Y., Ueno S., Saeki Y., Yanagihara T. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes. Federation of European Biochemical Societies Letters 1992; 314(1)23–25, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Tang M. X., Maestre G., Tsai W., Liu X., Feng L., Chung W., Chun M., Schofield P., Stern Y., Tycko B., Mayeux R. Relative risk of Alzheimer disease and age at onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. American Journal of Human Genetics. 1996; 58: 574–584, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tang M. X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B. Y., Mayeux R. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. Journal of American Medical Association 1998; 279(10)251–255, [CROSSREF], [CSA]
   Google Scholar
• Tuokko H., Hadjistavropoulos T. An assessment guide to geriatric neuropsychology. Lawrence Erlbaum, Mahwah, NJ 1998
   Google Scholar
• Tycko B., Lee J. H., Ciappa A., Saxena A., Li C -M., Feng L., Arriaga A., Stern Y., Lantigua R., Shachter N., Mayeux R. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals. Archives of Neurology. 2004; 61: 1434–1439, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Van Broeckhoven C., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., Martin J. J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genetics 1992; 2: 335–339, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wadley V. G., Haley W. E. Diagnostic attributions versus labeling: Impact of Alzheimer's disease and major depression diagnoses on emotions, beliefs, and helping intentions of family members. Journal of Gerontology: Psychological Sciences 2001; 56B(4)P244–P252, [CSA]
   Google Scholar
• Wilson R. S., Bennett D. A., Gilley D. W., Beckett L. A., Barnes L. L., Evans D. A. Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Archives of Neurology 2000a; 57: 1718–1723, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wilson R. S., Gilley D. W., Bennet D. A., Beckett L. A., Evans D. A. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. Journal of Neurology and Neurosurgery Psychiatry. 2000; 69: 172–177, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yeo G., Gallagher-Thompson D., Lieberman M. Variations in dementia characteristics by ethnic category. Ethnicity and the dementias, G. Yeo, D. Gallagher-Thompson. Taylor and Francis, Washington, DC 1996; 21–30
   Google Scholar
• Zubenko G. S. Clinicopathologic and neurochemical correlates of major depression and psychosis in primary dementia. International Psychogeriatrics 1996; 8: 219–223, Suppl 3[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Zubenko G. S., Moossy J., Kopp U. Neurochemical correlates of major depression in primary dementia. Archives of Neurology. 1990; 47: 209–214, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zubenko G. S., Moossy J., Martinez A. J., Rao G., Claassen D., Rosen J., Kopp U. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Archives of Neurology 1991; 48: 619–624, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar